Figure 5From: Systematic review and meta-analysis on the adverse events of rimonabant treatment: Considerations for its potential use in hepatology Forest plot graphic assessing the risk to be free of treatment discontinuation due to neurologic adverse events at rimonabant dosages of 5 and 20 mg.Back to article page